sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Updated 10/6/2026, 3:28 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics, Inc. | Sale | $1,909,665 | Congleton Jon Chief Executive Officer, Director | 75,000 sh | at $25.46 | Filed Oct 2, 5:53 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $3,005,303 | Slingsby Brian Taylor Director | 104,320 sh | at $28.81 | Filed Sep 24, 9:49 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $209,136 | Warren Eric Chief Commercial Officer | 7,438 sh | at $28.12 | Filed Sep 22, 6:48 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $85,740 | Karydas Daphne Director | 3,000 sh | at $28.58 | Filed Sep 17, 5:41 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $193,189 | Warren Eric Chief Commercial Officer | 7,437 sh | at $25.98 | Filed Aug 25, 5:16 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $58,785 | Rodman David Malcom Chief Medical Officer | 2,170 sh | at $27.09 | Filed Aug 12, 7:33 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $199,885 | Warren Eric Chief Commercial Officer | 7,438 sh | at $26.87 | Filed Jul 23, 6:39 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $11,036 | Rodman David Malcom Chief Medical Officer | 416 sh | at $26.53 | Filed Jul 20, 9:00 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $291,441 | Congleton Jon Chief Executive Officer, Director | 10,700 sh | at $27.24 | Filed Jul 15, 8:58 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $556,671 | Rodman David Malcom Chief Medical Officer | 20,407 sh | at $27.28 | Filed Jul 15, 8:58 PM ET | Filing | |
| MLYS Mineralys Therapeutics, Inc. | Sale | $65,781 | Rodman David Malcom Chief Medical Officer | 2,171 sh | at $30.30 | Filed Jul 10, 7:15 PM ET | Filing |